Spatiotemporal interplay of severe acute respiratory syndrome coronavirus and respiratory mucosal cells drives viral dissemination in rhesus macaques

Mucosal Immunology

Volumn 9, Issue 4, 2016, Pages 1089-1101

  Liu, L ^a   Wei, Q ^b   Nishiura, K ^a   Peng, J ^a   Wang, H ^a   Midkiff, C ^c   Alvarez, X ^c   Qin, C ^b   Lackner, A ^c   Chen, Z ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b INSTITUTE OF LABORATORY ANIMAL SCIENCE   (China)

^c TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ADULT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; IMMUNE RESPONSE; LANGERHANS CELL; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTIC INFILTRATION; LYMPHOID TISSUE; MACROPHAGE; MONOCYTE; MUCOSA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RESPIRATORY TRACT MUCOSA; RHESUS MONKEY; SARS CORONAVIRUS; T LYMPHOCYTE; UPPER RESPIRATORY TRACT; VIRAL CLEARANCE; VIRION; VIRUS REPLICATION; VIRUS SHEDDING; ANIMAL; CELL CULTURE; CELL DIFFERENTIATION; CELL MOTION; CORONAVIRIDAE; HUMAN; IMMUNE EVASION; IMMUNOLOGY; INNATE IMMUNITY; PHYSIOLOGY; RESPIRATORY MUCOSA; SEVERE ACUTE RESPIRATORY SYNDROME; VIROLOGY; VIRUS LOAD;

ANIMALS; CELL DIFFERENTIATION; CELL MOVEMENT; CELLS, CULTURED; CORONAVIRUS; DENDRITIC CELLS; HUMANS; IMMUNE EVASION; IMMUNITY, INNATE; MACACA MULATTA; MACROPHAGES; RESPIRATORY MUCOSA; RNA, VIRAL; SEVERE ACUTE RESPIRATORY SYNDROME; T-LYMPHOCYTES; VIRAL LOAD; VIRUS REPLICATION; VIRUS SHEDDING;

EID: 84975830697     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2015.127     Document Type: Article

References (37)

1. Drosten, C. et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med. 348, 1967-1976 (2003).
2. Buchholz, U. et al. Contact investigation of a case of human novel coronavirus infection treated in a German hospital, October-November 2012. Eurosurveillance 18, 1-7 (2013).
3. Zaki, A.M., van Boheemen, S., Bestebroer, T.M., Osterhaus, A.D. & Fouchier, R.A. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N. Engl. J. Med. 367, 1814-1820 (2012).
4. Nicholls, J.M. et al. Time course and cellular localization of SARS-CoV nucleoprotein and RNA in lungs from fatal cases of SARS. PLoS Med. 3, e27 (2006).
5. Richt, J.A. et al. Recently emerged swine influenza A virus (H2N3) causes severe pneumonia in Cynomolgus macaques. PLoS One 7, e39990 (2012).
6. Thibeault, S.L., Rees, L., Pazmany, L. & Birchall, M.A. At the crossroads: mucosal immunology of the larynx. Mucosal Immunol. 2, 122-128 (2009).
7. Bergthaler, A. et al. Viral replicative capacity is the primary determinant of lymphocytic choriomeningitis virus persistence and immunosuppression. Proc. Natl. Acad. Sci. USA 107, 21641-21646 (2010).
8. Matloubian, M., Kolhekar, S.R., Somasundaram, T. & Ahmed, R. Molecular determinants of macrophage tropism and viral persistence: importance of single amino acid changes in the polymerase and glycoprotein of lymphocytic choriomeningitis virus. J. Virol. 67, 7340-7349 (1993).
9. Norris, B.A., Uebelhoer, L.S., Nakaya, H.I., Price, A.A., Grakoui, A. & Pulendran, B. Chronic but not acute virus infection induces sustained expansion of myeloid suppressor cell numbers that inhibit viral-specific T cell immunity. Immunity 38, 309-321 (2013).
10. Hickman, H.D. et al. Anatomically restricted synergistic antiviral activities of innate and adaptive immune cells in the skin. Cell Host Microbe 13, 155-168 (2013).
11. Saba, E. et al. HIV-1 sexual transmission: early events of HIV-1 infection of human cervico-vaginal tissue in an optimized ex vivo model. Mucosal Immunol. 3, 280-290 (2010).
12. To, K.F. et al. Tissue and cellular tropism of the coronavirus associated with severe acute respiratory syndrome: An in-situ hybridization study of fatal cases. J. Pathol. 202, 157-163 (2004).
13. Peiris, J.S. et al. Clinical progression and viral load in a community outbreak of coronavirus-Associated SARS pneumonia: A prospective study. Lancet 361, 1767-1772 (2003).
14. Ding, Y. et al. The clinical pathology of severe acute respiratory syndrome (SARS): A report from China. J. Pathol. 200, 282-289 (2003).
15. Wu, V.C. et al. Acute renal failure in SARS patients: more than rhabdomyolysis. Nephrol. Dial. Transplant. 19, 3180-3182 (2004).
16. Gu, J. et al. Multiple organ infection and the pathogenesis of SARS. J. Exp. Med. 202, 415-424 (2005).
17. Farcas, G.A. et al. Fatal severe acute respiratory syndrome is associated with multiorgan involvement by coronavirus. J. Infect. Dis. 191, 193-197 (2005).
18. Chen, Y. et al. Rhesus angiotensin converting enzyme 2 supports entry of severe acute respiratory syndrome coronavirus in Chinese macaques. Virology 381, 89-97 (2008).
19. Qin, C. et al. An animal model of SARS produced by infection of Macaca mulatta with SARS coronavirus. J. Pathol. 206, 251-259 (2005).
20. Liu, L. et al. Epithelial cells lining salivary gland ducts are early target cells of severe acute respiratory syndrome coronavirus infection in the upper respiratory tracts of rhesus macaques. J. Virol. 85, 4025-4030 (2011).
21. Crescitelli, R. et al. Distinct RNA profiles in subpopulations of extracellular vesicles: Apoptotic bodies, microvesicles and exosomes. J. Extracell. Vesicles 2, 20677-20686 (2013).
22. Deneka, M., Pelchen-Matthews, A., Byland, R., Ruiz-Mateos, E. & Marsh, M. In macrophages, HIV-1 assembles into an intracellular plasma membrane domain containing the tetraspanins CD81, CD9, and CD53. J. Cell. Biol. 177, 329-341 (2007).
23. Koppensteiner, H., Banning, C., Schneider, C., Hohenberg, H. & Schindler, M. Macrophage internal HIV-1 is protected from neutralizing antibodies. J. Virol. 86, 2826-2836 (2012).
24. Welsch, S., Keppler, O.T., Habermann, A., Allespach, I., Krijnse-Locker, J. & Krausslich, H.G. HIV-1 buds predominantly at the plasma membrane of primary human macrophages. PLoS Pathog. 3, e36 (2007).
25. Geijtenbeek, T.B. et al. Identification of DC-SIGN, a novel dendritic cellspecific ICAM-3 receptor that supports primary immune responses. Cell 100, 575-585 (2000).
26. Sulahian, T.H. et al. Human monocytes express CD163, which is upregulated by IL-10 and identical to p155. Cytokine 12, 1312-1321 (2000).
27. Buechler, C., Ritter, M., Orso, E., Langmann, T., Klucken, J. & Schmitz, G. Regulation of scavenger receptor CD163 expression in humanmonocytes andmacrophages by pro-And antiinflammatory stimuli. J. Leukoc. Biol. 67, 97-103 (2000).
28. Gousset, K. et al. Real-Time visualization of HIV-1GAGtrafficking in infected macrophages. PLoS Pathog. 4, e1000015 (2008).
29. Hladik, F. et al. Initial events in establishing vaginal entry and infec tion by human immunodeficiency virus type-1. Immunity 26, 257-270 (2007).
30. Li, B.J. et al. Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque. Nat. Med. 11, 944-951 (2005).
31. Lawler, J.V. et al. Cynomolgus macaque as an animal model for severe acute respiratory syndrome. PLoS Med. 3, e149 (2006).
32. Law, H.K. et al. Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells. Blood 106, 2366-2374 (2005).
33. Cheung, C.Y. et al. Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis. J. Virol. 79, 7819-7826 (2005).
34. Rivollier, A., He, J., Kole, A., Valatas, V. & Kelsall, B.L. Inflammation switches the differentiation program of Ly6Chi monocytes from antiinflammatory macrophages to inflammatory dendritic cells in the colon. J. Exp. Med. 209, 139-155 (2012).
35. Chomarat, P., Dantin, C., Bennett, L., Banchereau, J. & Palucka, A.K. TNF skews monocyte differentiation from macrophages to dendritic cells. J. Immunol. 171, 2262-2269 (2003).
36. Spiegel, M., Schneider, K., Weber, F., Weidmann, M. & Hufert, F.T. Interaction of severe acute respiratory syndrome-Associated coronavirus with dendritic cells. J. Gen. Virol. 87 (Pt 7), 1953-1960 (2006).
37. Yen, Y.T., Liao, F., Hsiao, C.H., Kao, C.L., Chen, Y.C. & Wu-Hsieh, B.A. Modeling the early events of severe acute respiratory syndrome coronavirus infection in vitro. J. Virol. 80, 2684-2693 (2006).